Recently, the new antipsychotic drug Ziprasidone Hydrochloride Capsules of Jiudian Pharmaceuticals were approved for marketing by the National Medical Products Administration. Jiudian Pharmaceuticals has become the first company in China to pass the consistency evaluation of this product. So far, the company has 33 products that have passed the consistency evaluation.

Ziprasidone is indicated for the treatment of acute and chronic schizophrenia, schizoaffective disorder, and various psychotic symptoms associated with other diseases, including obvious positive symptoms (such as hallucinations, delusions, disordered thinking, hostility and paranoia, etc.) and negative symptoms (such as slow response, emotional indifference, social withdrawal, few words, etc.), and can also reduce the emotional symptoms associated with schizophrenia (such as depression, guilt, anxiety, etc.). There are many neurotransmitters in the brain, such as dopamine and serotonin, which are like "messengers" that transmit information between nerve cells and regulate our emotions and thinking. Ziprasidone hydrochloride capsules can act on the receptors of these neurotransmitters in the brain. For example, it can block dopamine receptors, reduce excessive dopamine activity, and thus improve psychotic symptoms such as hallucinations and delusions; it can also regulate the function of serotonin, which helps stabilize emotions. In addition, the advantage of ziprasidone is that it has little effect on metabolism. It is one of the antipsychotic drugs with the lowest risk of causing metabolic abnormalities and has almost no effect on weight.

According to Minnet data, from 2019 to 2023, the sales of ziprasidone have been increasing year by year,  reaching 320 million yuan in 2023. As the first domestic company to pass the consistency evaluation of generic drugs for ziprasidone hydrochloride capsules, Jiudian Pharmaceuticals will occupy a favorable position in market competition.

The approval of ziprasidone hydrochloride capsules not only reflects the research and development strength of Jiudian Pharmaceuticals, but also is a microcosm of domestic pharmaceutical companies breaking through technical barriers and serving the people's livelihood and health. In the future, the company will always stay true to its original aspiration and be committed to providing patients with more high-quality and efficient drugs to protect public health.